Soochow University, School of Pharmacy, Dean and Professor.

He was selected by the Chinese Academy of Sciences under the "Hundred Talents Program" (2006), recipient of the Outstanding Youth Fund of the National Natural Science Foundation of China (2008), Jiangsu Province's "Shuangchuang Talent" (2011), Jiangsu Province's "Shuangchuang Team" (Leader Talent, 2014), and Director of Jiangsu Province's Key Laboratory of Diagnostic and Treatment Technology for Major Neuropsychiatric Diseases (2013).

He is mainly engaged in psychoneuropharmacology research and related drug development.

Doctor of Pharmacy, Shenyang Pharmaceutical University

He has served as Director of Scientific Research Department of Shenyang Pharmaceutical University, Director of Science and Technology Park of Shenyang Pharmaceutical University, Chairman of Shenyang Pharmaceutical University Science and Technology Park Co., Ltd, Director of Benxi Institute of Pharmaceutical Research of Shenyang Pharmaceutical University, Chairman and General Manager of Shenyang Pharmaceutical University Benxi Pharmaceutical Science and Technology Co., Ltd, Member of the Party Committee of the University, University Reserve Cadre, Director of Modern Pharmaceutical Industry Technology Research Institute of Liaoning Province, and Vice Chairman of Suzhou Guochen Bio-technology Co.

It used to be responsible for the establishment of the national (Liaoning) comprehensive platform for the creation of major new drugs and the national (Liaoning) platform for biopharmaceutical innovation and incubation bases; it was also responsible for the establishment of the Liaoning Provincial Collaborative Innovation Center for the Creation of Major New Drugs, the Liaoning Provincial Platform for Common Technological Innovation in the Biopharmaceutical Industry, and the Liaoning Provincial Research Institute of Modern Pharmaceutical Industry and Technology, and other new research and development institutes.

He has participated in the formulation of the "Tenth Five-Year Plan" and "Eleventh Five-Year Plan" strategies and plans for the development of national pharmaceutical science and technology innovation; participated in the preparation and validation of the guidelines for the declaration of the first batch of national scientific and technological major special projects for the creation of major new drugs; and presided over the formulation of the development plans for the biomedical science and technology industry of Liaoning Province, Shenyang City, and Benxi City for the "Tenth Five-Year Plan, Eleventh Five-Year Plan, and Twelfth Five-Year Plan".

Part-time jobs: Secretary General of the National Innovative Drug Industry-University-Research Strategic Alliance, Executive Director of Liaoning Provincial Economic and Cultural Development Promotion Association, Deputy Secretary General of Liaoning Provincial Pharmaceutical Society, Director of Liaoning Provincial Medical Insurance Research Association, Director of China Pharmaceutical Research and Innovation Promotion Association, Director of Suzhou Wuzhong District Industry and Commerce Federation; Editorial Board Member of Asian Journal of Pharmacy, Editorial Board Member of China Pharmaceutical Technology and Market Magazine, Editorial Board Member of China Pharmaceutical Research and Development Information Magazine.

He has worked as a clinical leader in a biopharmaceutical company, Vice President of Clinical Operations at Cannon Chemical, Senior Director of Greater China at ICON DOCS, Head of Clinical Operations at Kinder Hospira, and has been responsible for team management and departmental management at IQVIA and other international and domestic companies.

Responsible for and managed Phase I clinical trial programs in the US, Australia, Taiwan, and Hong Kong covering hematology and solid tumor therapeutic areas.